A new pan-European study has identified the key behavioural factors that influence whether healthcare professionals prescribe new, novel or non-routine treatments for patients with neurodegenerative diseases.

The International Osteoporosis Foundation (IOF) announces the launch of the online IOF Musculoskeletal Rare Diseases Training Course: From Diagnosis to Care, now available on the IOF Academy to clinicians worldwide.

Sleep disturbances are far more common among workers in mid-later life than previously believed, according to a study that links work-related stress to a range of wellbeing issues. 

New genetic risk factors have been identified for fibromyalgia syndrome.

The landmark study, which involved scientists at King’s College London, published in Nature Medicine, highlights how the nervous system plays an important role in the development of the disorder.

A study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the ”la Caixa” Foundation, found no increased risk of miscarriage, stillbirth or major congenital anomalies among women inadvertently exposed to ivermectin during the period from two weeks before conception to the first four weeks of pregnancy.

Researchers at the VIB and KU Leuven, together with international collaborators, have discovered that blocking autophagy – the body's natural recycling system for worn-out cell components – in specialized blood vessels can reduce inflammation in mice with psoriasis. Unlike many current therapies, this strategy reduces inflammation without weakening the immune system. The findings, published in the journal Immunity, reveal a promising new approach for treating chronic inflammatory and autoimmune diseases.